Company News in the Life Science Industry

»

Reset 

Wildflower Brands Featured in CannabisNewsWire Publication Discussing the Farm Bill’s Positive Effect on CBD Sales  

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019

SELLAS Life Sciences Reports 2018 Financial Results and Provides Business Update

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019

Better Choice Company Appoints Four New Board of Director Members

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019

Coherus BioSciences Announces New Employment Inducement Grants

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019
Related companies:  Coherus BioSciences, Inc.

resTORbio, Inc. Announces Closing Public Offering of Common Stock

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019
Related companies:  resTORbio, Inc.

Providence Cancer Institute to Present Findings on GR-MD-02 at the 2019 Keystone Symposia on Molecular and Cellular Biology

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019
Related companies:  Galectin Therapeutics Inc.

The observation status of Oncology Venture is removed

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019

Assure Holdings Announces Estimated Impact from Fourth Quarter 2018 Increase in Bad Debt Expense

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019

Correction to Financial Statement Bulletin of BBS-Bioactive Bone Substitutes Plc, published 22th March 2019 at 9:00 CET

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019

2018 Annual Report and Accounts and Notice of AGM 

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019
Related companies:  Verona Pharma plc

Correction: Removal of the MAR plate in the release: The observation status of Oncology Venture is removed

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019

IBA SA: transparency notification

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019
Related companies:  Ion Beam Applications

FDA Issues Complete Response Letter for Zynquista™ (sotagliflozin)

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019
Related companies:  LEXICON PHARMACEUTICALS, INC.

Lexicon Pharmaceuticals to Host Conference Call and Webcast Today, March 22, 2019 to Provide a Regulatory Update on Sotagliflozin in Type 1 Diabetes

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019
Related companies:  LEXICON PHARMACEUTICALS, INC.

Sanofi: FDA issues Complete Response Letter for Zynquista(TM) (sotagliflozin)

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019

Initiation Of Phase III Clinical Trial Of BAN2401 In Early Alzheimer's Disease

TOKYO, March 22, 2019 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced that a global Phase III clinical study (Clarity AD/Study 301) of BAN2401, an anti-amyloid beta protofibril antibody, in patients with early Alzheimer's disease has been initiated.... Read more ››

By: PR Newswire Association LLC. - 22 Mar 2019
Related companies:  BioArctic AB | Eisai Inc.

GBT Reports Fourth Quarter and 2018 Results

MONTEVIDEO, Uruguay, March 22, 2019 /PRNewswire/ -- Biotoscana Investments S.A. (B3: GBIO33), a biopharmaceutical group that operates in Latin America, announced today its results for the 4Q18 and 2018.

Read more ››
By: PR Newswire Association LLC. - 22 Mar 2019
Related companies:  BIOTON S.A. | Biosearch Life | Biofarm S.A.

WuXi AppTec Reports Strong 2018 Annual Results

SHANGHAI, March 22, 2019 /PRNewswire/ -- WuXi AppTec Co., Ltd. (stock code: 603259.SH / 02359.HK), a leading global pharmaceutical and medical device open-access capability and technology platform company with global operations, announces its audited annual results for the year ended December... Read more ››

By: PR Newswire Association LLC. - 22 Mar 2019
Related companies:  WuXi AppTec, Inc. | WuXi AppTec Inc. | WuXi AppTec Advanced Therapies

HS-UK Look Forward to an Exciting Optrafair 2019

HARLOW, England, March 22, 2019 /PRNewswire/ -- Haag-Streit UK (HS-UK), the leading manufacturer and distributor of gold-standard optometry and ophthalmic equipment, is looking forward to an exciting Optrafair 2019, at the... Read more ››

By: PR Newswire Association LLC. - 22 Mar 2019

Nuo Therapeutics Provides Update on Ongoing Interactions with Centers for Medicare & Medicaid Services

GAITHERSBURG, Md., March 22, 2019 /PRNewswire/ -- Nuo Therapeutics, Inc. (OTCQB: AURX) ("Nuo" or the "Company"), today provided an update on ongoing interactions with Centers for Medicare & Medicaid Services' (CMS) Coverage and Analysis Group (CAG) representatives. As previously... Read more ››

By: PR Newswire Association LLC. - 22 Mar 2019
Related companies:  Nuo Therapeutics, Inc.
«  1  2 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies